DHR - Earnings call transcript Q4 2017

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Please stand by, we're about to begin. My name is Tracey, and I will be your conference facilitator this morning. At this time, I would like to welcome everyone to the Danaher Corporation's Fourth Quarter 2017 Earnings Results Conference Call. All lines have been muted to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. now call will to I Instructions] turn over the Mr. [Operator Relations. Vice President Gugino, of Matt Investor Mr. Gugino, your may you begin conference.

Matt Gugino

G the section the today our Thank all this you, presentation our and on of Quarterly non-GAAP us measures information us call of provided thanks I'd this and Dan the XX, will for section Tom call, Tracey. until Good the The Investors of Vice & until morning XXXX. the today, Earnings. everyone, Comas, Events archived on our call like of Officer. call. will remain available during that www.danaher.com, website President Presentations, heading under Executive and required Financial are today's Chief President Investors SEC available and Executive call replay joining are next Officer; be Joyce, will and later point out quarterly any our A February and our portion supplementing the other archived relating earnings under Chief to release, audio website, financial by heading Regulation also the to the slide be call. reconciliations and on With our

significant pending approvals. have of or certain the and describe year-over-year. and quarter decreases devices, presentation, may that are company XXXX, supplemental materials materials describe of metrics period-to-period and the all in factors and remarks Unless financial We the of company-specific references products The these year-over-year certain submitted During otherwise fourth performance. to that for operations continuing metrics which performance. describe the will in year-over-year references impacted more impacted factors and to regulatory the relate we supplemental additional noted, financial to increases all certain applications also

forward-looking or will of a including regarding our will uncertainties, During make risks the believe occur including Securities those These forward-looking subject the or filings, Federal statements in These materially we are to differ any date in law. required statements, turn number the set speak might do Laws, today. are of that that call any statements and statements only from With or make future. events we developments statements update anticipate that, results we may as to and forward-looking forth the statements forward-looking the within that assume meaning we actual not call, made, and any by SEC I'd like except obligation as of to they the over forward-looking Tom. to

Tom Joyce

good and Thank Matt, morning, you, everyone.

our I’d of made the to Before we we quarter, touch plan. the in this morning get CFO to regarding like announcement details transition on the briefly

the Executive Vice will transition President Dan, and gradual without with working office the and a Executive of privilege to it been January we an post member I’m Dan many and as McGrew, succeed XXXX. platforms of of As Officer Financial will continue will Comas of Danaher retirement. on diagnostics CFO to X, he you. Chief saw, Chief sure saying January you XXXX, our as of it of X current as has dental a a on Dan that be continue announced that our Matt goes Group begins

and past all is it stewardship, be your without Danaher us the guidance leadership, For thoughtful today valued at your longtime not where Danaher XX of strategic have years, would friendship. outstanding and vision, financial humility.

organically will so operational CFO, his know you important the experience of investor President roles had a Investor guidance M&A, years the able to provide we his during continue demonstrated We in post-XXXX CFO number be Matt Relations. qualified a uniquely important an highly. and to CFO Matt take our ensure with With of platforms. value Many experience tenure growth Matt of as strategic as that leadership played with Danaher Vice a But on is his with five relations Matt consistently of results. XX McGrew as this strategic past extensive across superior Danaher. from has Danaher, to he in very counsel. of to positon counsel company’s work audit, has us We four and internal are his also Dan’s transition Group to that leverage you’ll role Throughout pleased integral seamless with time to lets’ both inorganically. and look forward get with Matt role our and helping to and transition

how We X.X% a gross performance, of Danaher. as earnings very throughout improved solid while better, example of adjusted we are increased marketing how revenue core and strong momentum lowered We operating was very to XXXX These margin This we results points and with share investments Danaher and encouraged in to to for our delivered capped the demonstrate year core playbook. solid a model by operating we’re growth, expansion. stronger the drive the pleased quarter built R&D a our core double-digit nearly XXXX. per G&A, accelerating all and delivering fourth basis team expansion growth. continues build we XX%, margins Danaher run XX margin growth, sales great

full differentiated drive of revenue X.X% four commercial three growth including core in year, organic our helped growth, the our portfolio, mid-single digit out execution For good investments segments. reporting growth and

for in XXXX. $XX.X growth flow free nearly of position year-on-year deployment Our more total annual cash that $X.X We significant in us revenues helps resulting are billion. XXXX, capital mid-teens generated now in billion

Our will of represents free nearly we acquisitions, From $XXX their perspective, income respective on ratio exceeded cash-to-net our in M&A income. of enhance has free the net million year cash strategic XXX%, capital XXXX platforms. which flow which help deployed bolt-on an was each XXth conversion XXXX in consecutive XX and

PALL most encouraged great remain our Nobel Biocare. acquired the larger Phenomenex, recently and performance by at businesses, also Cepheid, We

quarter teams’ Gross margin for was life These testament a margin the execution consistent system. grew to led fourth acceleration sales China XXX the both of of double both Core year-on-year. currency by points, and single revenue diagnostics revenues of US the are the increased continuing adjusted now India lead was increased increase markets, billion, by to as five In Turning increased XXX acquisitions Europe tools growth basis the Western four with and X.X%, fourth digits. $X.XX, year EPS XX% core full digit sciences margin an grew and to of our impact and X% diluted quarter, the markets results our digits EPS using were the $X.X expanded we by platforms revenue by our mid-single between and up grew X.X% that Geographically way. led growth adjusted basis translation representing net high Danaher platforms. X.X%. quarter operating points to to $X.XX business while bringing as XX.X%, saw high Fourth X.X%. developed

counting execution Flow take revenue X.X%, Now market improved the performance ongoing platform let’s detailed to new quarterly In team which execution, Cytometry and by highest reported quarter fourth driven and commercial the platforms portfolio. take XX% better performance. look marks grew life a single driven in sciences, up more believe topline at our delivered share the primarily innovations results by was and core particle revenue basis core margins growth and XXX expected DBS four Beckman increasing core led over both was growth across reported continues businesses. second Life high This Sciences over broad rate product sciences product in profit years. We operating the based with increase XX%, outstanding operating strong by consecutive was points. across digit Life than for new margin revenue quarter, Beckman and innovations. the core

core setting Over was rate, flows, up the such led launching Several led the and markets. mid-single environmental low XX products. at work food, these three growth by pharmaceutical strong biologic revenue genomic business the by digits, medical China, in increased address revenue Beckman higher at approximately Sciex refreshed areas markets. years, well the portfolio research new continued continued end strength digit and past has as end new primarily Western Europe up single for and in Microsystem’s a its Leica and products of performance. in Core growth

Phenomenex continued had go-to-market rate to XX%, as leverage grew Phenomenex other’s since single very addition, microelectronics quarter, revenue Sciex our its well. and businesses to Pall, use perform core we are best both single business each At In nearly technologies the good capabilities. very growth starting quarterly high and digits acquired growing core a as revenue

combination and management and as innovation on This IDBS, In disruptions scientific October, impacted the efforts nicely businesses acquisition science our capture, better enabling to and space. in a its these informatics results. rebounded life quarter successfully to platform scientific our provides sciences their insights. life software platform sciences from of with hurricane research addition, IDBS’s accelerate software decisions. the enable year and In faster that note, instrumentation process researches the finished better data in strong a report biopharma third to make customers on will helping manage leader closed a the industrial platform life

XX.X%. points revenues XXX Regionally operating our was reported Latin and the grew America America. X%. broad Beckman with digits delivered solid by to margin margin product reported and diagnostics, at increased Leica revenue in blood immunoassay, lines gas single digit operating advanced AQT to XXX China the most perform core by by now Moving strength and Europe. chemistry mid-single product was At as continued XX.X% core increased points well. rate growth particular growth, in lines. and and and lines. by increased Coulter, urinalysis At led histology Radiometer, in and revenue demand growth regions, basis driven Western led core across high clinical core our North to low in Core increased grew revenue digit Biosystems Growth revenue core product staining single increased both quarter, our both basis based

outstanding quarter. major all by in and the Turning driven team revenue growth than had to increased product XX% greater Cepheid, an lines Core geographies.

mid-teens acquired full expected when of by almost test Cepheid’s achieved from marketing delivery acquisition. menu expansion The is a DBS serving. increasing November, of tools and grew growth transformative XXXX the basis tools, to commercial outperformance execution, business Cepheid increase rate combination number at and by generate base approximately new market first DBS more installed revenue Since they customers strong year commercial with expand potential increased of leads For to operating driven This it expansion, improvements visibility, an year company. the key are points. basis helping instruments. the last its above over gross ever management. was These across improved Overall Cepheid, helped which margin has we have funnel the tremendous embraced of the from XXXX, the Cepheid a announced XX%, has we on-time core points two just in double also team and breakeven margins was XXX deliver meaningfully the and

and As a market market position gain continues Cepheid believe share. leading to expand result, its we

specialty operating increased declined. margins consumables operating businesses, line XX.X% By was to our our Dental with offset Turning in segment, in by X.X% expectations. equipment dental orthodontics was line, revenue and and as and product reported and down declines was reported was traditional implants core core Growth margin profit revenue slightly. our both in performance consumables.

of As negatively expected equipment rate declines our was difficult moderate, XXXX. the growth realignment first and distributor these to started in impacted the persist manufacture of by We consumable has relationships. conditions through market recent traditional certain anticipate the to half however, business

initiatives the businesses. China. has to meaningfully single We had last the past approximately two they’ve but Nobel growth digits and performance mid-single increased of has and increased our a in margins, starts force DBS execution progress. quarter, two team sales new high revenue be customer of Biocare three-year with tools streamline acquisition, made Nobel products each R&D proxies specialty years. America and continue the spend along the from core operating in our launched tremendous core more pose to digit the sales only driven particular and increase new growth improved XX% Not XX%, pleased Nobel the years. with by December than their These consumables also helped by over of marked growing XX has anniversary in great North the by

reported our by with led attributed marking quality was deafening continued Western and The environmental product to digits in platform. the high quarter, offerings increased initiatives water grew America a identification, demand Videojet to North XX.X%, geographies. related digit and and based core up capped another for as packaging and and in segment, out-growth revenue solutions margin lines XX.X% points off at primarily now a In solutions driven margin revenue operating gain great demand and and single reported revenue operating growth by The major core Moving most increased with X%. revenue Videojet fourth XX within spend our and strong productivity Core broad basis mid-single consumables. increased declined by coating business returns product to in our share. equipment applied from rate, year color quarter the decreased and across compound increased Europe. market core to

five a of revenue digit strategic margins years, averaged also has completed Bolton past core Videojet and continued growth, acquisitions. mid-single expand the to Over number

revenue in acquisitions had best since of One growth XXXX. acquired Laetus those of core we its quarter the business

As and trade is leading Laetus supplier of for a pharmaceutical inspection reminder plants. packaging a track systems

With has tracking pharmaceutical packaging the market awareness growth generated mid-single well positioned revenue help believe and low-single up was core color is In vertical X-Rite greater at up businesses, of solutions we our and while tools digits, within Laetus the DBS forward. demand Esko going was for digits. and

Finally, join Zonen chemistry in of that relied performance closing systems water climate by Hach industrial also Kipp This applications wet and acquisitions, to its digit municipal the two will mid-single analyzers opportunity in & growing Kipp broader offerings, a municipal parameters Kipp best deliver & and and management & was markets, and Hach’s the making research, core customers. specializes and AppliTek testing. across materials revenue rate. complement to cadence for provider AppliTek its by will is growth quarter, process that’s had as industrial Bolton a at Western quality, mid-single our resource core an turning solutions. with leading its instrumentation Zonen. existing quarter core deals China. revenue Hach our core Hach year, integrated meteorologist digits. and strength the us through to providing and of drive a solid of environmental continued suite upon nicely such healthy platform growth in Europe customer enhanced of help with our business end Zonen offer

to by We in a Danaher. and food, core XXXX commercial gas execution. accomplishment of team’s XXth primarily in continue teams to It’s tremendous both driven commitment consecutive increases and grew the growth, end best-in-class steel and a are low excited North worth revenue the to year testament noting marks America. that its oil welcome At markets, Chemtreat, digit Chemtreat’s improvement and to revenue at a single rate, their

to by significantly Lastly, double increased help drive Trojan driven healthy the demand a win delivering continues very to quarter to gains Trojan great execute improving had growth, rates American core markets. customer municipal and activity in market. digit North share relative its bidding well

wrap to a meaningful delivered double year. start cash to very and EPS the So build momentum we’re off our flow as generation we core year accelerate with fourth quarter growth; In results, and margin Danaher XXXX. saw up, adjusted helping and good pleased team revenue XXXX, capping improvement growth for the digit through

to on deployment also continued our executed a of focus have integration recent positions for We and Bolton number a that deals significant balance in well sheet on us strategic larger more capital a now of acquisitions, we XXXX.

system long of that we the with the believe of business portfolio, strength As ahead, power with our the we combined creation. to the Danaher achieve shareholder value foundation provide look us term

X%. quarter net to X.X% core assumer between of adjusted $X.XX, first guidance are initiating We diluted which $X.XX growth and EPS

full in expect range to adjusted $X.XX. diluted XXXX the net of be and $X.XX X% EPS to X.X% year growth and to continue We of core revenue

Matt Gugino

comments. now ready Thanks concludes formal are our Tracey, for Tom. questions. That we

Operator

[Operator Research. go with And Instructions] first Davis we’ll Melius Scott to

Scott Davis

clear a globally. globally. Let’s where core it step back clear, from I exceptional surprises can walk was bit, the us the was but up around let’s but growth step just pretty By came clear you the really, wasn’t world, business positive in

Tom Joyce

Scott it global was basis. really very positive on a

are all that markets. think time, perspective our I in right, quarter we’re from respects India, I continued course markets was take some and time softness saw markets, strength bit digits the of the I the in growth those throughout I in difference mid-single we’d globally the in performance the saw performance incremental we we in high growth we macro consistently year, good to many global in economic maybe in participate. across advantage markets in a growth frankly the US think where more both a fourth Of basis. we’re think And know expansion. China, But performance unique like course we well in of many which markets developed with is in good the East. growth the the in What in all what still was of real and and synchronous like rate Russia, the up Europe is on positioned a America Latin the exceptional the of on than a businesses high that improving continued a noteworthy was some in global In Middle a basis seen as places think places

advantage our of We quality life water north Now in strength each product our in our and obviously X% improved science particular respectively, and positioned clearly in well markets. businesses, expected, of performance opportunities were our consistent in those performance we take up to X% saw and businesses of identification. business diagnostic which sequentially businesses

I line a in overall perspective, incredibly geographic happening in I clearly macro to drivers. well but four the well think platforms those think positioned So five pretty relative to with what’s macro from

Scott Davis

of this see more year, that seen begs wait when let’s the reasonably X.X% in little That your you got Is and or made you’ve natural just the global to that still just So X%. question think comments comps there is guidance. be about to before Danaher, you something positive and the easy standard half of you’ve raise about bit we the January leads year macro. the it’s early first a conservative that guidance

Tom Joyce

anything near-term basis say that I we’ve wouldn’t a in on particular Scott. it’s seen

latter point year. very made, think you is which it’s it’s I to the more much the in early

have early just at and by we’ve we us What January think And updating little quarter gives this point unfolds. we feel good very this saw. as of finish we’ll watch throughout We I the this as carefully we obviously encouragement now year. the seen course for obviously it’s to But the guidance are of I about that we’ll and encouraged the be well. point think

Operator

to go with Tycho we’ll And Peterson next JPMorgan.

Tycho Peterson

model certainly delta Question stood out. on of our the to science in life terms relative

Beckman can Pall called quantify and You was and out from life there you then willing any life Can that XQ catchup affect dynamic out. quantify any science, what you budget you’re to call sciences was Phenomenex. up flush that there

Tom Joyce

our into X.X%, a a hurricane life kind like with so probably point That recovery, followed was hurricane it were ex flush, call That’s very there worried science was We think went January January more but only remained recovery orders. we strong some also have broadly. as our orders very was but X.X%. there best I up beginning of budget were that the benefit, science stance slightly So through life not the was about in strong. more

Tycho Peterson

this And wondering done cartridge can more just provide how these markets. question versus is of color then coming bit a has if of from new [HVDC][ph] incredibly launches other Cepheid, little trends well. this some on flu obviously on I’m you a much and versus

Tom Joyce

based performance think There broad execution. I of really Cepheid. from which Not a saw was contributed to We certainly number commercial enhanced a strong of that that. factors least were the

at new and business, we’ve the of our and additions customer new acquired things the is Cepheid base XX% since we addition, tracked our acquired customer since we One business. installed are the plus

and strength in flu very least we a challenging of certainly season. markets are is countries menu installed represents And Flu/RSV, think Xpress enhancement the the developed hybrid step midst perspective early menu far expansions driven does flu, introduced a from very developing have growth all a that season of think XXXX, think quarter, that performance commercial both continued the the back and the execution the in driven making Cepheid. patient as beyond performance of But in really Clearly with a all with strep in a contributor difference. is fourth I at strength the growth test drive well. and in base. in if strength the yes but certainly good I at in Yes, flu look that I at you number with you

Operator

Ross next go Muken Evercore with we’ll ISI. And to

Ross Muken

your start the on And in of the getting in the and thoughts updated how influence of on and business time of where of have recently trends with you on some particularly in control maybe pieces based the that’s pieces underlying some don’t closing still the you’ve terms maybe sort kind changes but the consumables. acquired made on I what’s on. the channel obviously guess terms some of of factors of playout of over the market Nobel. of to right, dental you’re mean exist the you’ve in starting some like terms of year to seen I and to Nobel on how what it noise are better, wins year. it thoughts of and and gone of able small been cadence your seems basic the like you’ve sort versus maybe seems in some Maybe

Tom Joyce

played with The line pretty much fourth we quarter out in what expected.

group points participate were are Starting XXXX some businesses little all we comments half performance the in to are High consistent was consumables some digits, there two represent especially there no of I are And industry. of second throughout encouraged high things a about seen pinpoint right markets we in Nobel. execution, of I as the that platform we we’ve And quarter wallet of the clearly We’ve number to fourth and our for a while single in mentioned across business, we’ve half to more those think have the past our taken of done being tough by? perform approaching attractive quarter things you We operating share single know talked the Nobel combined very up be in traditional of as in cost fourth new the a last seen XXXX. especially our on know quite size acquisition. question year finished And I in. my we’ve of operational well, and businesses pretty bit performance over of the a couple but from to yet that that a up with dental invest growth and segment. to bit a structure a are the general and number XXX little segment points difficult that, and those changes still markets basis strength earlier the sites from by a Gross over four, consumables, there’s we’re XX of third. from a encouraging down businesses of reduced office back up products, in continued digit a manufacturing in that in But maybe XXX with result R&D basis as high a dental nearly margins up of those in Could quite as number Ormco the as mentioned percent in products consumables XXXX sales, and a whole think think very reinvesting. year digit us. Mid-single consolidated Nobel. actually growth of that years. our then the terrific good well. XX% a XX I talking new new growth bunch I platform, we’ve year-on-year, companies dental just

are strong making out to secular drive so we value and great and franchises. and half seen create is we the percentage long the billion all that in these brands on platform. where good about percentage this we and enormous weakness we’ve over operational have dentistry progress $X trends to platform of smaller we’re and of a admittedly about of So and platform the that digital isn’t a platform. around Good Danaher today that represent But an continue the clearly improvements even and of doesn’t term overall feel

Ross Muken

That’s super helpful front. just the and maybe allocation on capital

of of to leverage get balance of a year, out the going to continues looks because were of in the a income. last the sheet you’re really or place. you versus your balance balancing be are levels kind it cash busy the staring as two. looks net like guess tuck-in tremendous you little over are back So quarter market bit manageable plus capacity like multiples, I on How you public the XXX% side free guys

like just help now? of think through environment right So looks that kind for you how us

Tom Joyce

that feel the over The executed to acquisitions year, course and ’XX during very we where certainly good of spend today were platforms, during the ’XX. deployment the the strategic our of year we preceded course of of that XX year past that particularly within we we a light capital We sit that was did the of couple the in the spend range had years about number the anticipated Ross. of and enhancements of in that the the

as As think platforms bit. XXXX, us the that Optimally be a opportunities advantage are they come free deploy above strategically flow sheet’s willing capital positions of in important balance we mentioned, our enter as we to stretch great I to I to at that would now today, we’d our It and that deals along. take of cash or really shape. for anyone

we we year. activity bit. feel So how the great about enter seen up We’ve pick a little

valuations and think tax of uncertainty, well. That has been anytime as will. worth if and things half the eliminate that I clearly good people activity the that about more you sellers. But their of pays you little and out of with in noting also half as determined, bit the out bodes uncertainty in of year the year, level probably it’s saw a help Second first own market, well think you here things that the reform boltons up may those for grows how I now might feeling open a confidence

Operator

next We’ll UBS. Winoker take with our question from Steven

Steven Winoker

than a maybe you But talk little impact sensitive more other color less Obviously the around XXX inflation the Dan takes about give a on to just price material cost are headwinds. mix gross could productivity in maybe other of guys your puts you versus lot basis the structure and margin, points. companies.

Dan Comas

right probably up it’s is points levels margin; the margin the big don’t drivers. step the are XXX We headwind relatively gross through the at you’re inflation. impact hose t It’s clearly very you direct good and modest. but expansion gross including XX% little gross all gross a X.X% up of driver have margins of of the mean fall It’s we on step-up, together continued year-on-year obviously much in labor I part from when sort a a right. of now, You’re a margin commodities been is And multi-year side. Cepheid at just Pall. bit that growth, a at get basis effort. core two had putting biggest big The

Steven Winoker

expect that continue? so And you to

Dan Comas

in margin get I at we at the we’re in had of as set year first margin about not we negative margin, we step up of points the not operating we expansion. of quarter of side, OMX, how but at – to many the basis range I think the took probably in falling core Yes, as in including up points to still saw core going terms basis think feel very And gross good up of core Cepheid we’re part some from next XX are another of remember, the our and on margin. actions margin OMX we high of gross ’XX. of XX to in you’ll latter positioned year this XXX ended well end ’XX the I very

Steven Winoker

just then points basis margin Solutions. of through And little more maybe at talk XX Environmental & gotten Applied the down a dynamics it

Dan Comas

execute Trojan us very in Sure, that was strong, to a kind fourth business a actions different with top early take being the both on was the factors, some of were a Hach and actions. cost and we upon having We It bottom opportunities growth on good couple of quarter bit primarily negative of quarter. water the line. But side particularly both let the them very little mix. side clear some to a those came

to You did strong just for it start they had a very see I year. saw their growth the January accelerate.

pretty off investments think still of So quickly paying some here. growth I are their

So I’m in And And to have of was of will course, across [PID] through think I have you’ll we those in terms had of again A improvement and that we terms we’re normalized But had. of track that going concerned. orchestrated strength year. dental. you’ll water the to given margin this see not we businesses. have the the good in sort a margins. uplift amount of in segment diagnostics see not year, And it kind continue I starting quarter back more very on earlier think fair here

Operator

Vertical Sprague next we’ll go Research. And Jeff to with

Jeff Sprague

could immediate when this economic expensing of lunge company. lot deals just asset reform, do and a you looking at couple you of just you fixed on these have fair way, boltons bolton as the the structured get just of target On the can and to are a obviously looking properties. tax amount a the change of things, Just at asset typically I assets through you where deals, of them ability guys structure context back look if provision that from deals you that to give Danaher and standpoint. us your you’re kind a of wondered little deals a

Tom Joyce

versus Jeff even to We where an oppose entity, that of were an as stock so we rate tax there’s assets around XX%. of now. say thought the incrementally to two perhaps ago would wrapped said always I sort be our we’re acquire reform. generally encouraged been December would more months we the advantage in

year. to probably probably tax XX magnitude of about more XX% XX% it’s five a be million. this the to I the in to being will it XXX now think think million be to close XX We for next toll a million talked going years. year like We

point, lower your even more with incrementally, acquisitions overtime. sort potentially and asset often that of often particularly tax to to even acquisitions the as more an like case, ETR to is So been finally do opportunity work there it’s still

Jeff Sprague

And then strong, around always business something growth of or But it belt you’re drive further Environmental do tempo restructuring when guess tightening the the edges. this like wondering the quite investment traditional on is more kind growth. some oriented? the doing Applied, more Obviously spend to restructuring seems or I is or and is its just oriented in there’s that

Tom Joyce

R&D on adding both of It’s the Hach feet street little and bit side. oriented, the both, growth side on more the

industrial municipal we good more in even year QX. gave We’re very up some they ramp side, the seeing through better to the latitude the and actually and got numbers it on

Jeff Sprague

longer now the months realignment working we’re or six so annualization there maybe And these so, or is Are And just so, through in associated than comparisons the around dental. of we somethings just or shifting in the the of of several working through that? with on kind dynamics just it’s business? kind happened distributor realignment still last in then growth months the finally the that

Tom Joyce

those relationships the beginning in last changed year. way a Jeff formal at

Sirona’s or need four a of be in sort that what two Patterson. number that of Schein five and Essentially to months is Dentsply series places with our equipment shift that largely of When terms exclusive related about we’re a imaging. of around line relationship adjustments in happens, changing relationship thing a involved made. So Henry with product arrangements particularly in there’s

form sell-out that adjustment comes along is the inventory associated the of in products, actually of have sell-in. with of impact that Some on inventory, that in further, can comes new the of some learnings form team, with etcetera sales shifting an which incentives

a take encouraged and half that tool little of to level quarter. to first as be profitability. side, that of it consumable system. the when you specially arrangements markets challenged well that to of its is seeing well of in has continue way are the our and growth business quite of the a playing much field first the think bit In of for year putting the At with the continuing a We believe moderate still together fourth exclusive work better to likely work to the in we improvement is end day traditional those through by the which it’s continuing between less of manufacturers more operational and the take through the altogether flattish dental quite been number high a improve the to of in of business meantime, perform come a way does place we’re adjustments half well, market will this months So perform their the system. part have the this We becomes that still distributors. series factors take year we that

Operator

America Merrill Bruin Lynch. take from De next of with question We’ll our Bank Derik

Derik De Bruin

follow-up. couple, and one quick a then got one one Just

expense, for interest So me? so the could net expense, you guide ’XX what’s interest remind

Dan Comas

million. XXX

Derik De Bruin

a demand. bio seeing stepping area some them that bit I’m you talk allocations side spend. the you some on the capital starting stuff mean see of wondering see in about could if of we’re in about talk companies on their And what on we’re sort the of up commentary space you’re of equipment about the pharma increasing Could pharma side? on process pick-ups talking to I or the and sort order what’s big little that and of sort directly those weighted you spending. hearing some to

Tom Joyce

businesses the We very a equipment Life today, would at molecules at more biologic market perform Phenomenex, in those at businesses Science, but at and bio-processing, Beckman on equipment not the well, continuing performance pharma have point Sciex, not side in and to quarter, feel of those trends in at the saw quarter all saw Leica not obviously biologic life as say well. a certainly biologic side all function some we from or exposure the the hurricane as third of pharma the performance in by science to good use significant Microsystem. of of good we continued businesses Each just to we Pall, molecules, where we do improved good the our across way demand trend And rate pharma clearly around about good in rate order overall fact as technologies the our demand, disruptions well. around but order recovery small single fourth

combined I be shape. pretty on to in continues molecules overall pharma the and small say, balance So would market, good biologics

Derik De Bruin

possible any CapEx side, diagnostics blow the And PAMA back? any or

Tom Joyce

early know to rates to in again relative are place. those just going Derik, really. Not you as PAMA

to associated more outside is think our broadly, It’s the again, there that new. further impact our but don’t modest again then this leverage limited only US United to Medicare us. will XX%of the customers the reduction for that’s As relatively reasonable spending exposure PAMA on impact with mitigates anything think certainly reimbursements which necessarily volume with and and a reimbursement being States, mentioned I previously, I outpatient

pricing I exposure a rationale on will would hospital in market central But fact PAMA that. there relatively again a suggest little like dynamics lab Medicare there’s market modest. are create US pressure, some be only bit reimbursement going and there, the it’s an of certainly competitive the diagnostics a in anytime think outpatient the to for additional basis

Operator

And Beuchaw we’ll Stanley. with Steve next go to Morgan

Steve Beuchaw

good is because minute two China didn’t a wonder geographic on spend about should call. on bit markets. news focused moderate budget out question, items China on are you a the a a how that you fair developed in ’XX; it given much have that amount question some just where this there do I a in Where liquidity could evolving ’XX. attention we relative call as First think talked the something here if of maybe things get the particularly there; China, or in, we to little as is you

Tom Joyce

grow China. growth significant from of science Product of amount business and the consistently We’ve quality are the in market life digits extraordinary our strong concerns I goods, Steve, in And in platforms with package in for us investment there both important the single ID a diagnostics has for pretty of and consumer think do, a middle growth of certain billion revenue drivers even positions government. China. dental the China. with secular each double Today water continues the we number receiving driver across $X times, in that I’ve number as been of China of an class digits Chinese China our to mentioned environmental support excess of high platform and quarters and years. in

if up a key you lines the number in Chinese really portfolio drivers this market. think well I growth So a back, with step it’s a of that boy is

have to our platforms, changes, impact of In I terms new Again five there. broadly change China. most think that’s supportive be much the of relatively in any of you don’t plan there’s across think a going I of a year

So the in pretty from one in general platforms. the of we market about Chinese each feel good continuing contributions

Dan Comas

One and the of were was through the for China in up basically double was things that encouraging quarter XXXX. we digit were XX%-XX% every we year

feeling good over it have but or It’s point now So we share, feels two bigger that are still for things pretty a pretty like a down there. momentum. good base kick

Steve Beuchaw

not medium organization. businesses about improvement the step commentary what you’ve product new investment think, if to thinking the the or up of some in how just Tom, in step picture pay-off. your and more core growth seeing vow at success the perceive question Good big to term, and a hear. to level learned are that helpful downstream across up and encouraging as hard for flow How will on long it’s last R&D, marketing commercial all way really spend be of It and I this investment, it of your on the success, effort. appropriate look is One couple sales the and really changing an the hey R&D to hear and here of organic in of guys growth at a execution quarter, in these

Tom Joyce

last clearly really for portfolio. drivers. not of of two the changes better made last evolution the years up in years portfolio is Steve Well number just we’ve to a of has a the five an aligned is so, probably the us. portfolio but years this that the have has markets over a that really growth quite set that in Many than or great that evolution the been evolution of Part over

products new we’ve increasingly services, And wired probably the terms of in history of internet continue our from investments on rates. of XXXX, in whose driving have from well. commercial Videojet specifically a we impact an R&D growth most evolve. leveraging a [Claro] with pipeline new tools rates. of but got can think in business we launch in the point finally customer to I way the in number today its evolution fully those and through the greater tools I see DBS the XXXX beyond having the are the I businesses it to by innovation, incrementing to important in leadership product point Hach’s importantly paid incremental growth as Even off I continued see higher execution example as system, tools role of DBS internet seen of have to of where things for the evolved that think to system lean think growth, censored most an which developed secondly, their robust in the levels businesses and also examples And play those our Danaher of we in in innovation. an on to we has the growth and and of each our perspective, will and rates

business the tools couple last done portfolio inorganically then incremental growth deals over the rates been years investment to our we’ve have evolution, the higher of of innovation, R&D drive to I the continued evolution and the the think on So Danaher obviously in system, rates. of finally

related our each Cepheid those of the and at You drive strategic innovation kind clearly on impacts the Nobel Phenomenex strategic Pall times an early investment Bolton stage can term and ability acquisitions, businesses what impact over growth have of of growth. through time and is having long our certainly most those look at recent impact. incremental XX And drive to but acquisitions, that

have, really a it’s things, combination executing Certainly plan. but of the So process. having think as a has learned that learning we I of a function in really lot a come

Operator

And next Richard we’ll with to Baird. Eastman

Richard Eastman

factor curious, will margin that you Pall’s to improvement if on margin quarter, ’XX. gross the a up Dan impact the Pall’s gross Pall, the a back sense little in mix the margin. circle bit and full speak you to just But you and just give as the calendar strength year big sciences flagged during to improvement we Could maybe just overall a of in us maybe life improvement margin in margin expansion. for that up and here and I’m Pall could

Dan Comas

businesses and It I’ve their margin sales up Though to margins, good driver but none turned those all seeing particularly this doing of good seen off sciences their the digits. thing that quarter, improved broad the in science expansion. science broad was margin put same in of the sort the gross in of thing improvement. that know I that, core business the better margin. of stepping was say Rick the Pall growth R&D we’re would one the grew pretty marketing. margin mid-single life based. Sciex number is time and acquisition, the gross life since G&A, clearly we was based as [indiscernible] was [OP][ph] job and up I big has when points you up As operating we’re helps. And encouraging Though in gross growth expanding the improvement of the a as then a it the leveraging their a businesses business been and XXXX it, are purchased they that a are life chunk and noted the margins; high-teens basis Beck big

stepping Back getting up our up. point step investing while grow about to we’re Tom’s those margins investment. and growth So

Richard Eastman

here, and assuming Pall, fourth core you how the margin new look here as life maybe the well as at for stepped to here going off level a in for rebounded, look fourth the the sciences? Pall were margin Again and life when at structural PI is out grow gross leverage quarter up with growth quarter forward you sciences both do off

Dan Comas

more I’d to look them Rick carefully. have at

in next fourth cost step to believe sales, of kind seasonal life lot life at benefit which it quarters, real. of science some this but I specifically the changes is profile equipment there’s science. strong. a I have know made But look And the structural to in quarter were across you with couple the very of As we’ve in going up

Richard Eastman

if dental, at had Tom see the And suggested then revenue. would I just look question flattish first think maybe dental, of half on we last follow-up ’XX you

does investment points growth But you ’XX, So half. topline curious basis we given we perhaps a growth ’XX. the do for margin I’m to drive XXX little have the dental of great to bit of [dental]? outlook enough look do What the in XX deal when around sales back of without have improvement enough restructuring, at plan for the in like look expectation a margin

Tom Joyce

XXXX. at to dollars number invested I’ve cited sales different those balanced and you We’ve productivity that and but recall. areas, pretty of continue drive in we’ve that last over of same and marketing we’ll we’ve the may in R&D enhanced think we’ve do time a the in I numbers as applied well a couple of years invested in number to and restructuring

pretty and I XXXX. think and ’XX and approach think I well balance, it’s we any I we in that ’XX a in will so shook And differently anticipate that balance don’t

Operator

today Doug our Schenkel from with final take & question Company. We’ll Cowen

Doug Schenkel

going solid effect. even to I’m on guys had quarter for normalized start hurricane a you Pall;

encouraging. at to safe in XXXX. least customer earlier comments bio is on subsequent Specific an you’ve seen in improvement or inventory it demands to Your dynamics some trends normalization production you rebalancing the to earlier order is that say mentioned of

Tom Joyce

an we market order that are couple of in the XXXX, know, do demand Doug customers improvement order profile, to third It it slow and levels we number course saw good think say performance was late others the is in normalized, of even cases to in solid because I quarter, and and certainly point you trends those to a quarter think down I order fourth the production improve. safe trends the and trends that. a saw adjust in in during the of a

we’re So that. by encouraged

Doug Schenkel

something close to of going at guidance in just XXXX back rationale. the earlier maybe out we covered And to discussion the topic length by

And second, in math that you’ve we saying two from know one, on that to not much there year. rates conservative And as with fully the to rate original to earlier saw guidance the that on history guidance You have want fully were are And of those clear adjusted response you don’t you that least seemingly the to dynamic to would in not based of guidance relative I prudently what a $X.XX as current tax out QX you year said, earlier an full be in FX any in tending January you mentioned that on to guidance. cut other EPS question. lower at was pull in think based revenue reflected confirm just things, especially in forward current our for that QX.

Tom Joyce

that. try me let answer Doug to

have to We a December years sort it’s in XX when – XX, of January. avoided we’ve we adjusted guidance get been XX, the

recognized also I McGrew’s next year will that call quick. be too Matt early, too January feels first Just call.

January looking to tailwinds there, some whether point you’re sort suddenly are demand, not December of I’m there all right numbers. a here. things up numbers, But good out they QX So demand, change to

more from the a the offsets probably of dollar weakness and rate. benefitting count, but offsets a the there, few a are on modest. are are optimistic little We higher further that Yes, probably share tax we

things about feeling if we update year. good you we’ll opportunities pretty through are, have to continue, net-net where and So of we those good are plenty the

Operator

time, question-and-answer would turn the today’s this additional closing Gugino to conclude any like I back call does or remarks. This session. Mr. for At to

Matt Gugino

joining Thanks for us. Tracey and everyone thanks

all day for around questions. We’re

Operator

todays’ you your conference. We for thank participation. does conclude This

You may now disconnect.

Danaher (DHR) 30 Jan 182017 Q4 Earnings call transcript